160 related articles for article (PubMed ID: 9035104)
41. Binding affinities of anti-acetylcholine receptor autoantibodies in myasthenia gravis.
Bray JJ; Drachman DB
J Immunol; 1982 Jan; 128(1):105-10. PubMed ID: 7054275
[No Abstract] [Full Text] [Related]
42. [Value of TE671 cells in the detection of anti-acetylcholine receptor antibodies].
Kennel P; Vilquin JT; Fonteneau P; Tranchant C; Poindron P; Warter JM
Rev Neurol (Paris); 1993; 149(12):771-5. PubMed ID: 7997736
[TBL] [Abstract][Full Text] [Related]
43. Seronegative myasthenia gravis.
Vincent A; McConville J; Farrugia ME; Newsom-Davis J
Semin Neurol; 2004 Mar; 24(1):125-33. PubMed ID: 15229799
[TBL] [Abstract][Full Text] [Related]
44. Rhabdomyosarcoma cell line can be used for the isolation of soluble acetylcholine receptor and for assaying blocking and modulating autoantibodies.
Wu JT; Astill M; Lloyd C; Salmon VC
J Clin Lab Anal; 1993; 7(1):11-8. PubMed ID: 8426270
[TBL] [Abstract][Full Text] [Related]
45. Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis.
Shiraishi H; Motomura M; Yoshimura T; Fukudome T; Fukuda T; Nakao Y; Tsujihata M; Vincent A; Eguchi K
Ann Neurol; 2005 Feb; 57(2):289-93. PubMed ID: 15668981
[TBL] [Abstract][Full Text] [Related]
46. [Auto-antibodies against acetylcholine receptors in myasthenia gravis].
Fabien N; Huchet FX; Sanmarco M; Dubucquoi S; Wagner S; Yamamoto AM
Presse Med; 2001 Oct; 30(28):1414-8. PubMed ID: 11688208
[TBL] [Abstract][Full Text] [Related]
47. Myasthenia and neuroborreliosis with excessively high acetylcholine-receptor antibodies.
Finsterer J
Scand J Infect Dis; 2007; 39(2):187-90. PubMed ID: 17366045
[TBL] [Abstract][Full Text] [Related]
48. Epitopes on human acetylcholine receptor defined by monoclonal antibodies and myasthenia gravis sera.
Heidenreich F; Vincent A; Roberts A; Newsom-Davis J
Autoimmunity; 1988; 1(4):285-97. PubMed ID: 2485125
[TBL] [Abstract][Full Text] [Related]
49. [Antibodies to acetylcholine receptor. Diagnosis and therapeutic interest in myasthenia gravis (author's transl)].
de Crousaz G
Ann Chir; 1980 Mar; 34(3):188-92. PubMed ID: 7369693
[No Abstract] [Full Text] [Related]
50. Myasthenia gravis: a model disorder of acetylcholine receptors.
Drachman DB
Res Publ Assoc Res Nerv Ment Dis; 1987; 65():65-82. PubMed ID: 3330842
[No Abstract] [Full Text] [Related]
51. alpha-Bungarotoxin displacing antibody in myasthenia gravis.
Barkas T; Simpson JA
J Clin Lab Immunol; 1982 Nov; 9(2):113-7. PubMed ID: 7154056
[TBL] [Abstract][Full Text] [Related]
52. Antibodies to acetylcholine receptors as probes of receptor structure and pathological agents in myasthenia gravis.
Lindstrom J
Prog Clin Biol Res; 1981; 63():419-28. PubMed ID: 6171828
[No Abstract] [Full Text] [Related]
53. Fetal acetylcholine receptor inactivation syndrome and maternal myasthenia gravis: a case report.
D'Amico A; Bertini E; Bianco F; Papacci P; Jacobson L; Vincent A; Mercuri E
Neuromuscul Disord; 2012 Jun; 22(6):546-8. PubMed ID: 22316496
[TBL] [Abstract][Full Text] [Related]
54. Specificities of antibodies to acetylcholine receptors in sera from myasthenia gravis patients measured by monoclonal antibodies.
Tzartos SJ; Seybold ME; Lindstrom JM
Proc Natl Acad Sci U S A; 1982 Jan; 79(1):188-92. PubMed ID: 6948300
[TBL] [Abstract][Full Text] [Related]
55. Adult onset acquired myasthenia gravis in three Great Dane littermates.
Kent M; Glass EN; Acierno M; Shelton GD
J Small Anim Pract; 2008 Dec; 49(12):647-50. PubMed ID: 18684140
[TBL] [Abstract][Full Text] [Related]
56. Suppression of experimental myasthenia gravis by a B-cell epitope-free recombinant acetylcholine receptor.
Yi HJ; Chae CS; So JS; Tzartos SJ; Souroujon MC; Fuchs S; Im SH
Mol Immunol; 2008 Nov; 46(1):192-201. PubMed ID: 18799218
[TBL] [Abstract][Full Text] [Related]
57. Structure of the acetylcholine receptor and specificities of antibodies to it in myasthenia gravis.
Lindstrom JM
Ciba Found Symp; 1982; (90):178-96. PubMed ID: 6923807
[TBL] [Abstract][Full Text] [Related]
58. The main immunogenic region of acetylcholine receptors does not provoke the formation of antibodies of a predominant idiotype.
Killen JA; Hochschwender SM; Lindstrom JM
J Neuroimmunol; 1985 Aug; 9(3-4):229-41. PubMed ID: 4019748
[TBL] [Abstract][Full Text] [Related]
59. [Biochemical approaches to neuromuscular junction disorders].
Takamori M
Rinsho Shinkeigaku; 1996 Dec; 36(12):1363-4. PubMed ID: 9128412
[TBL] [Abstract][Full Text] [Related]
60. Polymyositis: reduction of acetylcholine receptors in skeletal muscle.
Pestronk A; Drachman DB
Muscle Nerve; 1985; 8(3):233-9. PubMed ID: 4058467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
